LAS VEGAS, NV – DigiPath Labs, a subsidiary of DigiPath, Inc. (OTCQB: DIGP), an independent cannabis lab testing and media firm, is pleased to announce that it has signed a laboratory testing agreement with The Cannavative Group, a fully licensed medical cannabis cultivator and producer located in Washoe County, Nevada.
DigiPath Labs will test all cannabis products grown and produced by The Cannavative Group for potency, terpenoids, moisture content, foreign matter, heavy metals, microbials, mycotoxins, and pesticide residue.
Todd Denkin, President of DigiPath, Inc., stated, “The Cannavative Group’s commitment to excellence and focus on producing high quality CBD products while emphasizing terpene profiles, is really what this industry needs, and we are glad to be a part of it. Even though it’s just the beginning of the cannabis industry in Nevada, we are still leading the way with the most stringent testing when compared with other states.”
“DigiPath Labs’ quick turnaround, high capacity, and amazing customer service is what made us want to work with them,” said Kristin Ehasz of The Cannavative Group. “We want to produce the highest quality cannabis products, and working with Digipath’s team we know we will be able to accomplish that.”
DigiPath Labs’ state-of-the-art Las Vegas laboratory was developed to elevate the standard for cannabis testing. Carefully selected equipment and verified standard operating procedures work together to ensure reliable, replicable results.
About DigiPath, Inc.
DigiPath, Inc. is an independent cannabis testing and media firm that supports the cannabis industry’s best practices for reliable testing and delivers cannabis news coverage and education about the cannabis industry. DigiPath’s two business units are DigiPath Labs and TNM News Corp. DigiPath Labs™ is working to set the industry standard for testing all forms of cannabis-based products using FDA-compliant laboratory equipment and proprietary standard operating procedures (SOP) to ensure product safety and efficacy. TNM News Corp. has pioneered a cannabis-focused news network, The National Marijuana News, which delivers news, interviews, and education on all things cannabis.
For more information please visit http://www.digipath.com/.
About The Cannative Group
The Cannavative Group includes Cannavative Farms, a medical cannabis cultivation facility, and Cannavative Extracts, a medical cannabis production facility, both located in the state of Nevada where the highest quality medical marijuana flower is grown, harvested, extracted and sold to Nevada State-certified medical marijuana dispensaries.
For more information, go to http://www.cannavativegroup.com.
This press release contains “forward-looking statements” that include information relating to future events, and future financial and operating performance. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the Company’s need for additional funding, governmental regulation of the cannabis industry, the demand for the Company’s products, the introduction of new products, the Company’s ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company’s liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in the Company’s filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting DigiPath, please refer to the Company’s recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.